Clinical Trial

Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast Cancer

Name: Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast Cancer — clinical trial record (NCT07579286)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LumiNOde

Recruiting

View on ClinicalTrials.gov →

Summary

Sentinel lymph node biopsy (SLNB) is the standard of axillary lymph node surgical staging in patients with early breast cancer. The main goal of the study is to abandon axillary surgery in patients over 59 years old with early, luminal A, clinical lymph node negative breast cancer.

Trial Details

NCT Number	NCT07579286
Lead Sponsor	N.N. Petrov National Medical Research Center of Oncology
Conditions	Early Breast Cancer
Enrollment	100 participants
Start Date	2023-07-27
Primary Completion	2027-05-25 (estimated)
Study Completion	2027-05-25 (estimated)
Updated on ClinicalTrials.gov	2026-05-12